Gerd Pluschke
Gerd Pluschke is an expert in Infectiology at University of Basel (Switzerland). As of October 2026, ScienceLeadR ranks Gerd Pluschke in the top 1% of experts worldwide for Skin Ulcer. Gerd Pluschke has authored 215 publications, the most recent in 2026. SLR score: 687 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Dermatology - Pharmacy - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1998 - 2026
Number : 215
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The Mycobacterial cyt-bc 1 Oxidase as a Drug Target: Activities of Arylvinylpiperazine Amides and Aminoquinazolines against Mycobacterium ulcerans. PMID 42446965 — mycobacterium, pharmaceutical preparations, ulcer, mycobacterium ulcerans, therapeutics, amides | J Med Chem | 2026 | 0 |
| Buruli ulcer. PMID 41413430 — buruli ulcer, skin, pharmaceutical preparations, ulcer, diagnosis | Nat Rev Dis Primers Top journal | 2025 | 1 |
| Pilot use of a mycolactone-specific lateral flow assay for Buruli ulcer: A case report from Japan. PMID 39175914 — buruli ulcer, pilots, ulcer, therapeutics, debridement, point-of-care testing | J Clin Tuberc Other Mycobact Dis | 2024 | 2 |
| The essential malaria protein PfCyRPA targets glycans to invade erythrocytes. PMID 38573856 — malaria, n-acetylneuraminic acid, erythrocytes, biological science disciplines, polysaccharides, parasites, lectins | Cell Rep | 2024 | 3 |
| How our molecular understanding of the pathogenesis of infection can improve diagnosis of Buruli ulcer. PMID 38073533 — infections, diagnosis, buruli ulcer | Expert Rev Mol Diagn | 2023 | 1 |
LeadR Networks
Main global connection map